Basic Information
Basic information for MIR646HG-213-16aa-1
Peptide Name MIR646HG-213-16aa-1
Genome Position chr20:60123809-60123856[+]
Species Human
Peptide Sequence MSNHLIYFLWLFNHNE
Peptide Length 16
Unique No (MIR646HG-206-16aa,MIR646HG-217-16aa-2,MIR646HG-246-16aa-1,MIR646HG-253-16aa-2)
Grand Average of Hydropathicity 0
Relative Molecular Mass 2348.58
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000228340;MIR646HG
Transcript ID/Name ENST00000653415;MIR646HG-213
Transcript Length 1846
Coding Ability 0.3814
DNA Sequence Corresponding to Peptide ATGAGCAACCACCTCATTTATTTTTTGTGGTTGTTTAACCACAATGAG
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :